WCM Investment Management LLC Acquires 347,984 Shares of DocGo Inc. (NASDAQ:DCGO)

→ Urgent dollar warning (From Stansberry Research) (Ad)

WCM Investment Management LLC lifted its position in shares of DocGo Inc. (NASDAQ:DCGO - Free Report) by 15.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,582,673 shares of the company's stock after purchasing an additional 347,984 shares during the quarter. WCM Investment Management LLC owned 2.49% of DocGo worth $14,489,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Deerfield Management Company L.P. Series C raised its position in DocGo by 55.7% in the 3rd quarter. Deerfield Management Company L.P. Series C now owns 4,764,000 shares of the company's stock valued at $25,392,000 after buying an additional 1,705,000 shares during the last quarter. State Street Corp raised its position in DocGo by 352.2% in the 2nd quarter. State Street Corp now owns 1,660,004 shares of the company's stock valued at $11,852,000 after buying an additional 1,292,941 shares during the last quarter. Sectoral Asset Management Inc. purchased a new stake in DocGo in the 3rd quarter valued at $3,472,000. Northern Trust Corp raised its position in DocGo by 425.3% in the 2nd quarter. Northern Trust Corp now owns 698,573 shares of the company's stock valued at $4,989,000 after buying an additional 565,582 shares during the last quarter. Finally, BlackRock Inc. raised its position in DocGo by 6.6% in the 2nd quarter. BlackRock Inc. now owns 6,029,276 shares of the company's stock valued at $56,494,000 after buying an additional 373,332 shares during the last quarter. 56.44% of the stock is owned by institutional investors and hedge funds.


Analysts Set New Price Targets

A number of research analysts have issued reports on DCGO shares. Canaccord Genuity Group reduced their price objective on DocGo from $10.00 to $9.00 and set a "buy" rating for the company in a research note on Thursday. Stifel Nicolaus reduced their price objective on DocGo from $11.00 to $8.00 and set a "buy" rating for the company in a research note on Wednesday. BTIG Research reduced their price objective on DocGo from $13.00 to $11.00 and set a "buy" rating for the company in a research note on Wednesday. Needham & Company LLC reduced their price objective on DocGo from $14.00 to $10.00 and set a "buy" rating for the company in a research note on Thursday, February 29th. Finally, Cantor Fitzgerald reduced their price objective on DocGo from $13.00 to $11.00 and set an "overweight" rating for the company in a research note on Thursday, February 29th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $10.83.

Get Our Latest Report on DCGO

DocGo Trading Down 2.8 %

Shares of DCGO stock traded down $0.10 on Friday, hitting $3.26. 1,058,818 shares of the stock were exchanged, compared to its average volume of 948,899. The firm has a market capitalization of $339.59 million, a PE ratio of 46.57, a P/E/G ratio of 0.33 and a beta of 0.91. DocGo Inc. has a one year low of $2.78 and a one year high of $10.82. The firm's 50 day moving average is $3.73 and its two-hundred day moving average is $4.70.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its quarterly earnings results on Wednesday, February 28th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.13 by ($0.07). The firm had revenue of $199.25 million for the quarter, compared to the consensus estimate of $195.48 million. DocGo had a return on equity of 2.01% and a net margin of 1.10%. On average, sell-side analysts expect that DocGo Inc. will post 0.35 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Michael J. Burdiek acquired 10,000 shares of the company's stock in a transaction that occurred on Thursday, March 14th. The shares were acquired at an average price of $3.61 per share, with a total value of $36,100.00. Following the acquisition, the director now owns 571,595 shares of the company's stock, valued at approximately $2,063,457.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 13.78% of the stock is currently owned by insiders.

DocGo Company Profile

(Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

See Also

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

→ Dems have chosen Biden replacement? (From Paradigm Press) (Ad)

Should you invest $1,000 in DocGo right now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Featured Articles and Offers

Search Headlines: